Acquisition strengthens lab informatics presence

News

Acquisition strengthens lab informatics presence

18 Aug, 2025

Clinisys has acquired Orchard Software from investment firm Francisco Partners, combining two leaders in laboratory information systems (LIS) to offer a broader, more flexible suite of solutions for healthcare, life sciences, and public health laboratories worldwide.

The acquisition unites Clinisys’s cloud-based LIMS and diagnostic solutions with Orchard’s proven offerings for physician office, reference, and veterinary laboratories. Together, the companies aim to provide scalable, end-to-end informatics solutions that streamline lab operations and enhance patient care.

“Orchard’s mission has always been to equip laboratorians with tools for high-quality, efficient care,” said Billie Whitehurst, Orchard CEO. “Joining Clinisys gives us the scale and innovation resources to take that mission further.”

Michael Simpson, CEO of Clinisys, added: “This acquisition strengthens our leadership in lab informatics and accelerates the development of next-generation solutions. By combining our expertise, we can better serve the full spectrum of diagnostic laboratories and support healthier, safer communities worldwide.”

Since acquiring Orchard in 2019, Francisco Partners has modernised its product suite, enhanced cloud capabilities, and strengthened leadership. The transaction brings new opportunities for growth and innovation in global lab informatics.

More information online

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Designed for semiconductor. Proven across industries.
Explore more Arrow
Pollution Solutions Online
Oil pipeline decommissioning in Wales secures environmental safety for future generations
Explore more Arrow
Petro Online
Flash point testing aligned with petrochemical compliance requirements
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow